Antibodies associated with TRALI: differences in clinical relevance

Transfusion

Volumn 59, Issue 3, 2019, Pages 1147-1151

  Kopko, Patricia M ^a   Bux, Jürgen ^b   Toy, Pearl ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIBODY; FRESH FROZEN PLASMA; GRANULOCYTE ANTIBODY; HLA ANTIGEN CLASS 2; HLA CLASS I ANTIBODY; HLA CLASS II ANTIBODY; HNA ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; BIOLOGICAL MODEL; BLOOD COMPONENT THERAPY; CASE STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; GRANULOCYTE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; NOTE; PATHOGENESIS; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; TARGET CELL; TRANSFUSION RELATED ACUTE LUNG INJURY; BLOOD DONOR; BLOOD TRANSFUSION REACTION; FEMALE; IMMUNOLOGY; MALE;

ANTIBODIES; BLOOD DONORS; FEMALE; HUMANS; MALE; TRANSFUSION REACTION; TRANSFUSION-RELATED ACUTE LUNG INJURY;

EID: 85058409770     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.15094     Document Type: Note

References (39)

1. Schmickl CN, Pannu S, Al-Qadi MO, et al. Decision support tool for differential diagnosis of acute respiratory distress syndrome (ARDS) vs cardiogenic pulmonary edema (CPE): a prospective validation and meta-analysis. Crit Care 2014;18:659.
2. Muller MC, van Stein D, Binnekade JM, et al. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion 2015;55:164-75.
3. Eder AF, Herron RM, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2019;50:1732-42.
4. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757-67.
5. Arinsburg SA, Skerrett DL, Karp JK, et al. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI. Transfusion 2012;52:946-52.
6. Bolton-Maggs PH. Serious hazards of transfusion—conference report: celebration of 20 years of UKhaemovigilance. Transfus Med 2017;27:393-400.
7. Funk MB, Guenay S, Lohmann A, et al. Benefit of transfusion-related acute lung injury risk minimization measures—German Haemovigilance data (2006–2010). Vox Sang 2012;102:317-23.
8. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
9. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992;32:589-92.
10. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
11. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA Class II antibodies in transfusion-related acute lung injury. Transfusion 2001;41:1244-8.
12. Reil A, Keller-Stanislawski B, Gunay S, et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008;95:313-7.
13. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009;49:440-52.
14. Keller-Stanislawski B, Reil A, Gunay S, et al. Frequency and severity of transfusion-related acute lung injury—German heamovigilance data (2006–2007). Vox Sang 2010;98:70-7.
15. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leukocyte antigen class II antibody. Br J Haematol 2002;116:673-6.
16. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-62.
17. Brander L, Reil A, Bux J, et al. Severe transfusion-related acute lung injury. Anesth Analg 2005;101:499-501.
18. McCullough J, Clay M, Press C, et al. Granulocyte agglutination. In: Granulocyte serology. A clinical and laboratory guide. Chicago: ASCP Press; 1988. p. 12-4.
19. Khoy K, Nguyen MV, Masson D, et al. Transfusion-related acute lung injury: critical neutrophil activation by anti-HLA-A2 antibodies for endothelial permeability. Transfusion 2017;57:1699-708.
20. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009;49:1825-35.
21. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case–control study. Am J Respir Crit Care Med 2007;176:886-91.
22. Bayat B, Tjahjono Y, Berghöfer H, et al. Choline transporter-like protein-2: new von Willebrand factor-binding partner involved in antibody-mediated neutrophil activation and transfusion-related acute lung injury. Arterioscler Thromb Vasc Biol 2015;35:1616-22.
23. ISBT Working Party on Granulocyte Immunobiology. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009;96:266-9.
24. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol 1999;105:322-9.
25. Hänsch GM, Radsak M, Wagner C, et al. Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener granulomatosis. Kidney Int 1999;55:1811-8.
26. Kelher MR, Banerjee A, Gamboni F, et al. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model. Transfusion 2016;56:3004-11.
27. Sachs UJ, Wasel W, Bayat B, et al. Mechanisms of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011;117:669-77.
28. Göhring K, Wolff J, Doppl W, et al. Neutrophil CD177 (NB1 gp, HNA-2a) expression is increased in severe bacterial infections and polycythaemia vera. Br J Haematol 2004;126:252-4.
29. Geppert TD, Lipsky PE. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 1985;135:3750-62.
30. Gosselin EJ, Wardwell K, Rigby WF, et al. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol 1993;151:1482-90.
31. Kopko PM, Paglieroni TG, Popovsky MA, et al. TRALI: correlation of antigen–antibody and monocyte activation in donor-recipient pairs. Transfusion 2003;43:177-84.
32. Kapur R, Kim M, Rondina MT, et al. Elevation of C-reactive protein levels in patients with transfusion-related acute lung injury. Oncotarget 2016;7:78048-54.
33. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-71.
34. Cooling L. Transfusion-related acute injury. JAMA 2002;288:315-6.
35. Toy P, Hollis-Perry KM, Jun J, et al. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004;44:1683-8.
36. Nicolle AL, Chapman CE, Carter V, et al. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004;14:225-30.
37. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788-99.
38. Silliman CC, Bercovitz RS, Khan SY, et al. Antibodies to the HLA-A2 antigen prime neutrophils and serve as the second event in an in vitro model of transfusion-related acute lung injury. Vox Sang 2014;107:7-82.
39. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009;113:2079-87.